Machine learning approaches to drug response prediction: challenges and recent progress
出版年份 2020 全文链接
标题
Machine learning approaches to drug response prediction: challenges and recent progress
作者
关键词
-
出版物
npj Precision Oncology
Volume 4, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-15
DOI
10.1038/s41698-020-0122-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dr.VAE: Improving drug response prediction via modeling of drug perturbation effects
- (2019) Ladislav Rampášek et al. BIOINFORMATICS
- Correction to: Predicting drug response of tumors from integrated genomic profiles by deep neural networks
- (2019) Yu-Chiao Chiu et al. BMC Medical Genomics
- Kernelized rank learning for personalized drug recommendation
- (2018) Xiao He et al. BIOINFORMATICS
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2018) John Heymach et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens
- (2018) Alexander Ling et al. PHARMACOLOGY & THERAPEUTICS
- DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity
- (2018) Benedict Anchang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
- (2018) Su-In Lee et al. Nature Communications
- Interpretable dimensionality reduction of single cell transcriptome data with deep generative models
- (2018) Jiarui Ding et al. Nature Communications
- Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature
- (2018) Yoosup Chang et al. Scientific Reports
- A novel heterogeneous network-based method for drug response prediction in cancer cell lines
- (2018) Fei Zhang et al. Scientific Reports
- Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
- (2018) Rafael Gómez-Bombarelli et al. ACS Central Science
- Cancer Drugs Approved Based on Biomarkers and Not Tumor Type—FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers
- (2018) Vinay Prasad et al. JAMA Oncology
- Deep learning in omics: a survey and guideline
- (2018) Zhiqiang Zhang et al. Briefings in Functional Genomics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
- (2018) Jin-Ku Lee et al. NATURE GENETICS
- clusterExperiment and RSEC: A Bioconductor package and framework for clustering of single-cell and other large gene expression datasets
- (2018) Davide Risso et al. PLoS Computational Biology
- Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics
- (2017) Michael Q. Ding et al. MOLECULAR CANCER RESEARCH
- Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
- (2017) Huipeng Li et al. NATURE GENETICS
- Rationalizing combination therapies
- (2017) NATURE MEDICINE
- PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
- (2017) Petr Smirnov et al. NUCLEIC ACIDS RESEARCH
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Gene isoforms as expression-based biomarkers predictive of drug response in vitro
- (2017) Zhaleh Safikhani et al. Nature Communications
- Advances in single-cell RNA sequencing and its applications in cancer research
- (2017) Sibo Zhu et al. Oncotarget
- A Computational Approach for Identifying Synergistic Drug Combinations
- (2017) Kaitlyn M. Gayvert et al. PLoS Computational Biology
- Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways
- (2016) M. Doherty et al. ANNALS OF ONCOLOGY
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Drug combination therapy increases successful drug repositioning
- (2016) Wei Sun et al. DRUG DISCOVERY TODAY
- Molecular graph convolutions: moving beyond fingerprints
- (2016) Steven Kearnes et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies
- (2016) Jennifer O'Neil et al. MOLECULAR CANCER THERAPEUTICS
- Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
- (2016) Alexander Aliper et al. MOLECULAR PHARMACEUTICS
- Reproducible pharmacogenomic profiling of cancer cell line panels
- (2016) Peter M. Haverty et al. NATURE
- Clonal genotype and population structure inference from single-cell tumor sequencing
- (2016) Andrew Roth et al. NATURE METHODS
- Optimization of drug combinations using Feedback System Control
- (2016) Patrycja Nowak-Sliwinska et al. Nature Protocols
- Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing
- (2016) Yuchao Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures
- (2016) Mohammed El-Kebir et al. Cell Systems
- Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
- (2016) Sudheer Gupta et al. Scientific Reports
- Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
- (2015) Xiao-xiao Sun et al. ACTA PHARMACOLOGICA SINICA
- Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
- (2015) Andrea Weiss et al. ANGIOGENESIS
- PharmacoGx: an R package for analysis of large pharmacogenomic datasets
- (2015) Petr Smirnov et al. BIOINFORMATICS
- The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
- (2015) Amber Johnson et al. DRUG DISCOVERY TODAY
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment
- (2015) Ayako Suzuki et al. GENOME BIOLOGY
- PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors
- (2015) Amit G Deshwar et al. GENOME BIOLOGY
- Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data
- (2014) Layla Oesper et al. BIOINFORMATICS
- Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
- (2014) Mehmet Gönen et al. BIOINFORMATICS
- Computational identification of multi-omic correlates of anticancer therapeutic response
- (2014) Lindsay C Stetson et al. BMC GENOMICS
- Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward?
- (2014) C. Hatzis et al. CANCER RESEARCH
- The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
- (2014) Terri Patricia McVeigh et al. EUROPEAN JOURNAL OF CANCER
- A community effort to assess and improve drug sensitivity prediction algorithms
- (2014) James C Costello et al. NATURE BIOTECHNOLOGY
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- DCDB 2.0: a major update of the drug combination database
- (2014) Y. Liu et al. Database-The Journal of Biological Databases and Curation
- SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
- (2014) Christopher A. Miller et al. PLoS Computational Biology
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- mRMRe: an R package for parallelized mRMR ensemble feature selection
- (2013) Nicolas De Jay et al. BIOINFORMATICS
- Precision Oncology: An Overview
- (2013) Levi A. Garraway et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison and validation of genomic predictors for anticancer drug sensitivity
- (2013) Simon Papillon-Cavanagh et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
- (2013) Michael P. Menden et al. PLoS One
- Targeting protein–protein interactions as an anticancer strategy
- (2013) Andrei A. Ivanov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Impact of high-throughput screening in biomedical research
- (2011) Ricardo Macarron et al. NATURE REVIEWS DRUG DISCOVERY
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients
- (2009) Elzbieta A Slodkowska et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
- (2008) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started